GBC Blog

Business Wire – March 10, 2020 – bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, is announcing the forthcoming launch of 3 different tests to address the COVID-19 epidemic and to meet the different needs of physicians and health authorities in the fight against this emerging infectious disease. bioMérieux has finalized…

March 11, 2020, Leah Lawrence – Researchers say they can distinguish between lesions that are benign and those that could become invasive — but the technology required is not yet used routinely. Testing only occurred among symptomatic patients. Circulating microDNA profiles may serve as a useful tool for lung cancer detection in symptomatic patients when…

By DAVID LIM and BRIANNA EHLEY 03/10/2020 06:56 PM EDT A looming shortage in lab materials is threatening to delay coronavirus test results and cause officials to undercount the number of Americans with the virus. The slow pace of coronavirus testing has created a major gap in the U.S. public health response. The latest problem…

As the threat of the novel coronavirus continues to grow globally, innovative biopharmaceutical companies are ramping up efforts to study the virus and develop vaccines and cures to protect individuals from contracting the virus. More than 75,000 cases have been confirmed worldwide—and the numbers are climbing with over 1,000 cases outside mainland China, where the…

Bethesda, Maryland (Feb. 18, 2020) – Patients at average risk of colorectal cancer who have a normal colonoscopy do not need to repeat screening for 10 years. It is common for polyps to be removed and tested during a colonoscopy, but the amount and size of polyps removed will change the patient’s follow-up screening schedule.…

With superbugs causing upwards of 35,000 deaths per year, the global antibiotic crisis is intensifying, says the World Health Organization (WHO)—and depending which direction policymakers go, antimicrobial resistance (AMR) could either be relieved or exacerbated by policy.  The problem: “Declining private investment and lack of innovation in the development of new antibiotics are undermining efforts to combat drug-resistant…

Science  10 Jan 2020: Vol. 367, Issue 6474, pp. 143-144, Mette Kalager & Michael Bretthauer National cancer screening programs, such as mammography for breast cancer, are widely implemented to reduce cancer incidence and mortality in high-income countries. Their introduction is also being considered in low- and middle-income countries. For many cancer types, the benefits and harms…

The FDA’s Center for Devices and Radiological Health (CDRH) recently released draft guidance — Safer Technologies Program for Medical Devices, or STeP — for the purpose of public comment. In the guidance, the FDA states its belief that STeP “will help patients have more timely access to these medical devices and device-led combination products by…

30 SEP 19, Georgia Green – A new blood test has been shown to identify different cancer types with a high degree of accuracy. When cancer cells die, they shed their DNA into the blood. Previous diagnostic tests work by identifying the genetic mutations present in the cancer cell DNA. However, this technique is limited…

Gunjan Bagla, Amritt, Inc., September 25, 2019 India’s Central Drugs Standard Control Organization (CDSCO), the country’s national regulatory authority for both drugs and medical devices (i.e., India’s equivalent of the United States’ FDA) is acting on a report submitted by its internal Drugs Technical Advisory Board (DTAB) to form a new division under the CDSCO.…